## 



## 

|||Page||
|---|---|---|---|
|Report ofthe Trustees|1|to|10|
|Report ofthe Independent<br>Auditors|11|to|14|
|Statemeat ofFinancial Activities||15||
|Balance Sheet||16||
|Cash Flow Statement||17||
|Notes to the Cash Flow Statement||18||
|Notes to the Financial Statements|19|to|30|





## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 




## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 




## 

## 

||||||||31.12.22|31.12.21|
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Endowment|Total|Total|
|||||fund|funds|fund|funds|funds|
|INCOME AND|||Notes|$|$|$|$|$|
|ENDOWMENTS<br>FROM|||||||||
|Donations and legacies|||3|1,403,129|300,352||1,703,481|466,758|
|Other trading activities|||4|14,991|||14,991||
|Investment<br>income|||5|202825'||3,777|206,402|154,858|
|Total|||||300,352|3,777|1,924,874|621,616|
|EXPENDITURE ON|||||||||
|Raising funds|||6|160,820||2255|163,075|390,095|
|Charitable<br>activities|||||||||
|Support the operational||costs of|||||||
|the RDTC in Moshi<br>IFDgeneral activities<br>Student sponsorship<br>ILDSactivities<br>Community<br>Skin Health Journal<br>Global Psoriasis Atlas<br>World Congress ofDermatology<br>WHO activities||||93,364<br>160,383<br>1302,542<br>99,226<br>81,669<br>90,912<br>9ir752|151,180<br>122,032<br>112,200<br>73,684<br>15,978||244,544<br>282,415<br>112,200<br>1,202,542<br>172,910<br>97,647<br>90,912<br>99,162|109,992<br>211,480<br>125,568<br>156,442<br>61,354<br>62,092<br>114,342<br>180,147|
|Total|||||475,074|2,255|2,465,407|1,411,512|
|Net gains/(losses)<br>on|||||||||
|investments||||(T7105i792)||(60,580)|(1,869,772)|29,885|
|NET|||||||||
|INCOME/(EXPENDITURE)<br>Transfers between funds|||(2,176,525)<br>18 ~079Z)||(174,722)<br>280,792|(59,058)|(2,410,305)|(760,011)|
|Net movement<br>in funds||||(2,457,317)|106,070|(59,058)|(2,410,305)|(760,011)|
|RECONCILIATION|OF||||||||
|FUNDS|||||||||
|Total funds brought forward||||14,379,592|277,412|1,133,561|15,790,565|16,550,576|
|TOTAL FUNDS CARRIED|||||||||
|FORWARD|||||||||





## 

||||||31.12.22|31.12.21|
|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment|Total|Total|
|||fund|funds|fund|funds|funds|
||Notes|$|$|$|$|$|
|FIXEDASSETS|||||||
|Tangible assets|14|64,334|||64,334|6,823|
|Investments|15|11,670,341||669,699|12,340,040|12,386,009|
|||11,734,675||669,699|12,404,374|12,392,832|
|CURRENT ASSETS|||||||
|Debtors|16|14,225|||14,225|33,135|
|Cash atbank and in hand||591,752|383,482|404,804|1,380,038|3,403,157|
|||605,977|383,482|404,804|1,394,263|3,436,292|
|CREDITORS|||||||
|Amounts<br>falling due within one|||||||
|year|17|(418,377)|||(418,377)|(38,559)|
|NET CURRENT ASSETS||187,600|383,482|404,804|975,886|3,397,733|
|TOTAL ASSETSLESS|||||||
|CURRENT LIABILITIES||11,922,275|383,482|1,074,503|13,380,260|15,790,565|
|NET ASSETS||11,922,275|383,482|1,074,503|13,380,260|15,790,565|
|FUNDS|18||||||
|Unrestricted<br>funds|||||11,922,275|14,379,592|
|Restricted funds|||||383,482|277,412|
|Endowment<br>funds|||||1,074,503|1,133,561|
|TOTAL FUNDS|||||13,380,260|15,790,565|





## 

||||31.12.22|31.12.21|
|---|---|---|---|---|
|||Notes|$|$|
|Cash flows from operating<br>activities|||||
|Cash generated<br>&om operations|||(344335)|(1,005,896)|
|Net cash used in operating activities|||(344,235)|(1,005,896)|
|Cash flows from investing<br>activities|||||
|Purchase oftangible fixed assets<br>Purchase offixed asset investments<br>Saleoffixed asset investments|||(63,005)<br>(4,033,439)<br>2,209,636|(2,562)<br>(12,414,303)<br>5,901,887|
|Interest received|||206,402|154,858|
|Net cash used in investing<br>activities|||(1,680,406)|(6,360,120)|
|Cash flows from financing<br>activities|||||
|Income attributable<br>toendowment|||3777|22,093|
|Expenditure<br>attributable<br>to endowment|||(2,255)|(2,935)|
|Net cash provided by financing<br>activities|||1,522|19,158|
|Change in cash and cash equivalents|in||||
|the reporting period<br>Cash and cash equivalents<br>at the|||(2,023,119)|(7,346,858)|
|beginning ofthe reporting<br>period|||3,403,157|10,750,015|
|Cash and cash equivaleats<br>at the end|of||||
|the reporting<br>period|||1,380,038|3,403,157|





## 

## 

|<br>ACTIVITIES|||OPERATIN||
|---|---|---|---|---|
||||31.12.22|31.12.21|
|Net expeaditure<br>for the reporting|period (as per the Statement of||$|$|
|Financial Activities)<br>Adjustments<br>for:|||(2,410,305)|(760,011)|
|Depreciation<br>charges<br>Losses/(gain)<br>on investments<br>Interest received<br>Income attributable<br>to endowment<br>Expenditure<br>attributable<br>to endowment<br>Decrease/(increase)<br>in debtors<br>Increase/(decrease)<br>in creditors|||5,494<br>1,869,772<br>(206,402)<br>(3,777)<br>2,255<br>18,910<br>379,818|2,023<br>(29,885)<br>(154,858)<br>(22,093)<br>2,935<br>(19,618)<br>(24,389)|
|Net cash used in operations|||(344435)|(1,005,896)|
|ANALYSIS OFCHANGES IN NET FUNDS|||||
||At|1.1.22|Cash flow|At31.12.22|
|||$|$|$|
|Net cash|||||
|Cash atbank and in hand|3,403,157||(2,023,119)|1,380,038|
||3,403,157||(2,023,119)|1,380,038|
|Total|3,403,157||(2,023,119)|1,380,038|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 




## 

## 


|4.|OTHER TRADING A|CTIVITIES||||||
|---|---|---|---|---|---|---|---|
|||||||31.12.22|31.12.21|
||World congress bidding|fees||||$ 14,991|$|
|5.|INVESTMENT INCOME|||||||
|||||||31.12.22|31.12.21|
||Porlfolio income<br>Bank interest|||||$ 206,402|$ 154,829<br>29|
|||||||206,402|154,858|
||RAISING FUNDS|||||||
||Raising donations<br>and|legacies||||||
|||||||31.12.22|31.12.21|
||Supportcosts|||||$ 110,153|$ 359,906|
||An analysis ofsupport costs is provided||in note 8.|||||
||Investment<br>management|costs||||||
|||||||31.12.22|31.12.21|
||Portfolio management|||||$ 52,922|$ 30,189|
||Aggregate<br>amounts|||||163,075|390,095|
|7.|CHARITABLE ACTIVITIES COSTS|||||||
||||||Grant|||
||||||funding of|||
||||||activities|Support||
|||||Direct|(seenote|costs (see||
|||||Costs|8)|note 9)|Totals|
||Support the operational<br>costs ofthe|||$|$|$|$|
||RDTC in Moshi<br>IFDgeneral activities<br>Student sponsorship<br>ILDSactivities<br>Community<br>Skin Health Journal<br>Global Psoriasis Atlas<br>World Congress ofDermatology<br>WHO activities|||151,180<br>69,399<br>112,200<br>379,195<br>73,684<br>25,799<br>2,678<br>9,623|52,350<br>257,642|93,364<br>160,666<br>565,705<br>99326<br>71,848<br>88,234<br>89,539|244,544<br>282,415<br>112,200<br>1,202,542<br>172,910<br>97,647<br>90,912<br>99,162|
|||||823,758|309,992|1,168,582|2,302,332|





## 

## 

|Kings College - London|$34,099|
|---|---|
|Charite University -Berlin|$64,038|
|Standing Voice|$55,505|
|Massachusetts<br>General Hospital<br>Mexico<br>Dermlink|$75,000<br>$10,000<br>$42,350|



## 

|SUPPORT COSTS|||||||
|---|---|---|---|---|---|---|
|||||Human|Governance||
|||Management|Finance|resources|cost's|Totals|
|Raising donations<br>and||$|$|$||$|
|legacies<br>Support the operational||85,906|20,652|2,398|1,197|110,153|
|costs ofthe RDTC in Moshi<br>IFDgeneral activities<br>ILDSactivities<br>Community<br>Skin Health||69,731<br>130364<br>313,799|20,038<br>20,436<br>20,252|2,398<br>2,398<br>2,398|1,197<br>7,568<br>229,256|93,364<br>160,666<br>565,705|
|Journal<br>Global Psoriasis Atlas<br>World Congress of||75,660<br>47,310|19,969<br>20,164|2,399<br>2,399|1,198<br>1,975|99,226<br>71,848|
|Dermatology<br>WHO activities||57,895<br>64,032|20,141<br>20,000|2,399<br>2415|7,799<br>3,292|88,234<br>89,539|
|||844,597|161,652|19,004|253,482|1478,735|
|Support costs, included|in the|above, are as follows|||||
||||Support||||
||||the||||
|||Raising<br>donations|operational<br>costsof|IFD||Community<br>Skin|
|||and|the RDTC|general|ILDS|Health|
|||legacies|in Moshi|activities|activrttes|Journal|
|Administration<br>salaries<br>Social security<br>Pensions<br>Office rent and related costs<br>Recruitment<br>fees<br>Meetings and travel<br>Website<br>Postage and stationery<br>Branding<br>Sundries<br>Legal, professional<br>and||$ 61,500<br>4,828<br>1,540<br>2,852<br>8,200<br>6,986|$ 54,411<br>4,828<br>1,350<br>2,852<br>6490|$ 85,300<br>4,829<br>1,540<br>2,852<br>33,238<br>2,505|$ 100,200<br>6,439<br>1,591<br>2,859<br>49,305<br>3341<br>389<br>68,963<br>1,427|$ 35,500<br>4,829<br>2,853<br>15,406<br>7,417<br>9,655|
|accountancy|||||34,690||
|Carried forward||85,906|69,731|130,264|269,104|75,660|





## 

## 

## 

|SUPPORT|C|OST|S - continued||||||
|---|---|---|---|---|---|---|---|---|
||||||Support||||
||||||the||||
|||||Raising|operational|||Community|
|||||donations|costsof|IFD||Skin|
|||||and|the RDTC|general|ILDS|Health|
|||||legacies|in Moshi|activities|activities|Journal|
|||||$|$|$|$|$|
|Brought forward||||85,906|69,731|130,264|269,104|75,660|
|Tfanlnlg|||||||15,866||
|President support costs|||||||28,829||
|Bank charges||||385|385|576|439|369|
|Foreign exchange variance||||19,113|19,112|19,112|19,112|19,112|
|Depreciation|oftangible||||||||
|fixed assets||||1,154|541|748|701|488|
|HR support||||2,398|2,398|2,398|2,398|2,399|
|Auditprs'<br>remunerhfion||||1,197|1,197|1,197|1307|1,198|
|Legal Tees||||||6,371|55,602||
|Trainhtg algl|resources||||||11,509||
|Board meeLhrg||costs|||||160,938||
|||||110,153|93,364|160,666|565,705|99,226|
||||||||31.12.22|31.12.21|
||||||World||||
|||||Global|Congress||||
|||||Psoriasis|of|WHO|Total|Total|
|||||Atlas|Dermatology|activities|activities|activities|
|||||$|$|$|$|$|
|Administration||salaries||30,500|48,000|47,088|462,499|461,000|
|Social security||||4,829|4,829|4,829|40,240|40,320|
|Pensions||||1,912|1,912|1,542|11,387|19,489|
|OAice rent and related costs||||2,853|2,853|2,853|22,827|14,189|
|Recruitment|fees|||||2,000|25,606|41,753|
|Meetings and travel||||7,216|||69,797|1,658|
|Website|||||||43,896|12,433|
|Postage and stationery|||||301||690|1,208|
|Branding|||||||81,123|18,215|
|Sundries|||||||1,427|301|
|Legal, professional|||and||||||
|accountancy||||||5,720|40,410|60,768|
|Tfaliinlg|||||||15,866|4,273|
|President support costs|||||||28,829|5,242|
|Bank charges||||369|369|369|3,261|3,579|
|Foreign exchange variance||||19,112|19,112|19,112|152,897|191,827|
|Depreciation|oftangible||||||||
|fixed assets||||683|660|519|5,494|2,023|
|HR support||||2,399|2,399|2315|19,004||
|Auditors'<br>remuneration||||1,198|1,198|1,198|9,590|9,101|
|Legal fees||||777|6,601|2,094|71,445||
|Training and|resources||||||11,509||
|Board meeting||costs|||||160,938||
|||||71,848|88,234|89,539|1,278,735|887,379|





## 


## 

## 

## 

## 

|STAFFCOSTS|||||||||
|---|---|---|---|---|---|---|---|---|
|Staff costs for the year|were $514,126|(2021|- $519,679), in respect||of nine members|of administration||staff|
|based in the UK and these are analysed||as follows:|||||||
|||||||2022||2021|
|||||||$||$|
|Agency and subcontract|staff|||||51,430||19,300|
|Wages and salaries|||||411,069||440,573||
|Social security costs||||||40,240|40,318||
|Employer contributions|to defined contribution||pension|schemes||11,387||19,488|
||||||514,126||519,679||



## 

|COMPARATIVKS FORTHE STATEMENT OFFINANCIAL|COMPARATIVKS FORTHE STATEMENT OFFINANCIAL|ACTIVITIES|||
|---|---|---|---|---|
||Unrestricted|Restricted|Endowment|Total|
||fund|funds|fund|funds|
||$|$|$|$|
|INCOME AND ENDOWMENTS FROM|||||
|Donations<br>and legacies|156,226|310,532||466,758|
|Investment<br>income|132,765||22,093|154,858|
|Total|288,991|310,532|22,093|621,616|
|EXPENDITURE ON|||||
|Raising funds|387,160||2,935|390,095|
|Charitable<br>activities|||||
|Support the operational costsofthe RDTC in|||||
|Moshi|24,234|85,758||109,992|
|IFDgeneral activities|125,598|85,882||211,480|
|Student sponsorship||125,568||125,568|
|ILDSactivities|156,442|||156,442|





## 

|13.|COMPARATIVES FORTHE STATEMENT|OFFINANCIAL|ACTIVITIES -continued|ACTIVITIES -continued||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Endowment|Total|
|||fund|funds|fund|funds|
|||$|$|$|$|
||Community<br>Skin Health Journal|8,575|52,779||61,354|
||Global Psoriasis Atlas|59,821|2,271||62,092|
||World Congress ofDermatology|114,342|||114,342|
||WHO activities|180,147|||180,147|
||Total|1,056,319|352,258|2,935|1,411,512|
||Net gains/(losses)<br>on investments|64,722||(34,837)|29,885|
||NKT INCOME/(EXPENDITURE)|(702,606)|(41,726)|(15,679)|(760,011)|
||Transfers between funds|(137,195)|137,195|||
||Net movement<br>in funds|(839,801)|95,469|(15,679)|(760,011)|
||RECONCILIATION OFFUNDS|||||
||Total funds brought forward|15,219,393|181,943|1,149240|16,550,576|
||TOTAL FUNDS CARRIED FORWARD|14,379,592|277,412|1,133,561|15,790,565|
|14.|TANGIBLE FIXEDASSETS|||||
||||Plant and|Office||
||||machinery|equipment|Totals|
||||$|$|$|
||COST|||||
||At 1January 2022|||18,569|18,569|
||Additions||60,622|2,383|63,005|
||At 31December 2022||60,622|20,952|81,574|
||DEPRECIATION|||||
||At 1January 2022|||11,746|11,746|
||Charge foryear||3,789|1,705|5,494|
||At 31December 2022||3,789|13,451|17,240|
||NET BOOKVALUE|||||
||At 31December 2022||56,833|7,501|64,334|
||At 31December 2021|||6,823|6,823|





## 

## 

|FIXEDASSETINVESTMENTS||||
|---|---|---|---|
|||Cash and||
||Listed|settlements||
||investments|perldlrlg|Totals|
||$|$|$|
|MARKET VALUE||||
|At I January 2022|12,386,009||12,386,009|
|Additions|2,363,115|1,670,324|4,033,439|
|Disposals|(1,611,241)|(598,395)|(2309,636)|
|Revaluations|(1,869,772)||(1,869,772)|
|At 31December 2022|11,268,111|1,071,929|12,340,040|
|NKT BOOK VALUE||||
|At 31December 2022|11,268,111|1,071,929|12,340,040|
|At 31December 2021|12,386,009||12,386,009|



## 

|||||Cash and||
|---|---|---|---|---|---|
||||Listed|settlements||
||||investments|pending|Totals|
||||$|$|$|
|Valuation|in 2022||11368,111|1,071,929|12,340,040|
|DEBTORS:||AMOUNTS FALLING DUE WITHIN ONE YEAR||||
|||||31.12.22|31.12.21|
|||||$|$|
|Trade debtors||||2,715|(1,373)|
|Prepayments||and accrued income||11,510|34,508|
|||||14,225|33,135|





## 

## 

## 

## 

|CREDITOR|S:|AMOUNTS FA|LLING D|UE WITHIN ONE|YEAR|||
|---|---|---|---|---|---|---|---|
|||||||31.12.22|31.12.21|
|||||||$|$|
|Trade creditors||||||268|5,306|
|Other creditors||||||5,907|11,044|
|Accruals and|deferred income|||||412,202|22,209|
|||||||418,377|38,559|
|MOVEMENT IN FUNDS||||||||
||||||Net|Transfers||
||||||movement|between|At|
|||||At 1.1.22|in funds|funds|31.12.22|
|||||8|$|$|$|
|Unrestricted|funds|||||||
|General fund||||14,379,592|(2,176,525)|(280,792)|11,922,275|
|Restricted funds||||||||
|IFDGeneral|||||44,963||44,963|
|IFDRDTC|||||(208,380)|208,380||
|IFDCommunity||Skin Health Journal|||(72,412)|72,412||
|ILDSGlobal|Psoriasis Atlas|||277,412|61,107||338,519|
|||||277,412|(174,722)|280,792|383,482|
|Endowment|funds|||||||
|IFD(Moshi RDTC) Endowment|||Fund|1,133,561|(59,058)||1,074,503|
|TOTAL FUNDS||||15,790,565|(2,410,305)||13,380,260|
|Net movement|in|funds, included|in the above are as follows:|||||
|||||Incoming|Resources|Gains and|Movement|
|||||resources|expended|losses|in funds|
|||||$|$|$|$|
|Unrestricted|funds|||||||
|General fund||||1,620,745|(1,988,078)|(1,809,192)|(2,176,525)|
|Restricted funds||||||||
|IFDGeneral<br>IFDRDTC<br>IFDCommunity<br>Skin Health Journal<br>ILDSGlobal Psoriasis Atlas||||166,995<br>55,000<br>1,272<br>77,085|(122,032)<br>(263,380)<br>(73,684)<br>(15,978)||44,963<br>(208,380)<br>(72,412)<br>61,107|
|Endowment|funds|||300,352|(475,074)||(174,722)|
|IFD(Moshi RDTC) Endowment|||Fund|3777|(2,255)|(60,580)|(59,058)|
|TOTAL FUNDS||||1,924,874|(2,465,407)|(1,869,772)|(2,410,305)|





## 

## 

## 

||||||Net|Transfers||
|---|---|---|---|---|---|---|---|
||||||movement|between|At|
|||||At 1.1.21|in funds|funds|31.12.21|
|||||$|$|$|$|
|Unrestricted|funds|||||||
|General fund||||15419,393|(702,606)|(137,195)|14,379,592|
|Restricted funds||||||||
|IFDGeneral<br>IFDRDTC|||||(36,643)<br>(24,117)|36,643<br>24,117||
|IFDCommunity||Skin Health Journal|||(51,206)|51,206||
|IFDPersons|with|Albinism|||(15,229)|15,229||
|IFDIACS|||||(10,000)|10,000||
|ILDSGlobal|Psoriasis Atlas|||181,943|95,469||277,412|
|||||181,943|(41,726)|137,195|277,412|
|Endowment|funds|||||||
|IFD(Moshi RDTC) Endowment|||Fund|1,149,240|(15,679)||1,133,561|
|TOTAL FUNDS||||16,550,576|(760,011)||15,790,565|



|||||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|---|---|---|
|||||resources|expended|losses|in funds|
|||||$|8|$|$|
|Unrestricted|funds|||||||
|General fund||||288,991|(1,056,319)|64,722|(702,606)|
|Restricted funds||||||||
|IFDGeneral<br>IFDRDTC||||24,010<br>187,209|(60,653)<br>(211,326)||(36,643)<br>(24,117)|
|IFDCommunity||Skin Health Journal||1,573|(52,779)||(51,206)|
|IFDPersons|with|Albinism|||(15,229)||(15,229)|
|IFDIACS|||||(10,000)||(10,000)|
|ILDSGlobal|Psoriasis Atlas|||97,740|(2371)||95,469|
|||||310,532|(352,258)||(41,726)|
|Endowment|funds|||||||
|IFD(Moshi|RDTC) Endowment||Fund|22,093|(2,935)|(34,837)|(15,679)|
|TOTAL FUNDS||||621,616|(1,411,512)|29,885|(760,011)|



## 

## 



## 

## 

## 

## 

## 

##